PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jpnSubmit a ManuscriptEmail AlertsAbout JPNJournal of Psychiatry and Neuroscience
 
J Psychiatry Neurosci. Mar 1996; 21(2): 123–127.
PMCID: PMC1188751
The role of estrogen in schizophrenia.
M V Seeman
Department of Psychiatry, University of Toronto, Clarke Institute of Psychiatry, Ontario, Canada.
Abstract
This paper reviews 3 recent studies from different clinics correlating psychotic symptoms with phases of the menstrual cycle in women with schizophrenia. The aim of the paper is to focus on the estrogen protection hypothesis which would suggest that low estrogen phases correlate with more severe symptoms, and high estrogen phases correlate with less severe symptoms. Although the methodology of the 3 studies was different, the hypothesis was essentially upheld. High levels of estrogens protect against symptom exacerbations in women with schizophrenia. A corollary to this finding is that, for optimal efficacy and safety, neuroleptic doses could be reduced at certain times of the month and increased at others.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1009K), or click on a page image below to browse page by page.
Articles from Journal of Psychiatry & Neuroscience : JPN are provided here courtesy of
Canadian Medical Association